Suchergebnisse - "Rejeski, Kai"

PubPharm (64)

31

Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL

enthalten in: HemaSphere | 2023

von Rejeski, K. | Blumenberg, V. | Iacoboni, G. | +18

32

Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy

enthalten in: European journal of nuclear medicine and molecular imaging | 2023

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +10

33

Shunt dependency in supratentorial intraventricular tumors depends on the extent of tumor resection

enthalten in: Acta neurochirurgica | 2023

von Teske, N. | Chiquillo-Domínguez, M. | Skrap, B. | +8

34

Functional connectivity MRI provides an imaging correlate for chimeric antigen receptor T-cell-associated neurotoxicity

enthalten in: Neuro-oncology advances | 2023

von Stoecklein, S. | Wunderlich, S. | Papazov, B. | +18

35

In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer

enthalten in: Oncoimmunology | 2023

von Xu, T. | Karschnia, P. | Cadilha, B. | +22

36

T-Zell basierte Immuntherapien in hämatologischen Neoplasien: Pathophysiologie und Risikomodelle von Immunotoxizität und Ansprechen

Erschienen: Habilitationsschrift, München, Ludwig-Maximilians-Universität, 2023

von Rejeski, K.

37

Immune effector cell-associated hematotoxicity : EHA/EBMT consensus grading and best practice recommendations

enthalten in: Blood | September 7, 2023

von Rejeski, K. | Subklewe, M. | Aljurf, M. | +34

38

The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

enthalten in: American Journal of Hematology | 2023

von Rejeski, K. | Wang, Y. | Albanyan, O. | +17

39

Infections after chimeric antigen receptor (CAR)‐T‐cell therapy for hematologic malignancies

enthalten in: Transplant Infectious Disease | 2023

von Kampouri, E. | Little, J. | Rejeski, K. | +3

40

Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy

enthalten in: European journal of nuclear medicine and molecular imaging | 2022

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +10